US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 4.3650
  • -0.0350-0.80%
Close Apr 25 16:00 ET
38.86MMarket Cap-4643P/E (TTM)

About Marker Therapeutics Company

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Company Profile

SymbolMRKR
Company NameMarker Therapeutics
Listing DateNov 7, 2016
Founded1991
CEODr. Juan Vera, M.D.
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4551 Kennedy Commerce Drive
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77032
Phone1-713-400-6400
Websitehttp://www.markertherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Juan Vera, M.D.
  • Director, President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • 581.92K
  • Anna Szymanska
  • Vice President, Quality
  • --
  • Tsvetelina Pencheva Hoang, PhD
  • Vice President, Research and Development
  • --
  • Nadia Agopyan
  • Vice President, Regulatory Affairs
  • --
  • N. David Eansor
  • Chairman of the Board
  • 93.32K
  • Dr. Katharine Knobil, M.D.
  • Independent Director
  • 62.71K
  • Steven A. Elms
  • Independent Director
  • 71.70K
  • John Wilson
  • Independent Director
  • 67.20K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg